Sexually Transmitted Infections clinical trials at UC Cancer
1 research study open to eligible people
Showing trials for
Study of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid Tumors
open to eligible people ages 18 years and up
This is a first-in-human, phase 1, open-label, dose-escalation study of STI-6643 administered by intravenous infusion in subjects with a relapsed/refractory advanced solid tumor.
at UCSD
Last updated: